European stock markets looked for direction on Tuesday as a partial easing of hostilities in the Middle East reduced some short-term geopolitical anxiety, even as energy market disruptions and central bank policy remained squarely in investors' sights.
At 03:04 ET (07:04 GMT) the pan-European Stoxx 600 was largely unchanged. Germany's Dax had slipped 0.1%, France's CAC 40 was flat and the U.K.'s FTSE 100 had moved lower by 0.4%.
Tensions between Iran and Israel showed signs of cooling after both sides said they had halted a recent escalation of attacks on one another. That development eased some market concerns about the prospect that U.S. President Donald Trump might be able to secure a peace deal with Tehran.
Despite the apparent lull, the Strait of Hormuz - a crucial corridor for roughly a fifth of the world’s oil and liquefied natural gas exports - remains effectively closed to tanker movements. The U.S. blockade of Iranian ports is set to remain in place, Mr. Trump has vowed, prolonging the disruption to marine energy logistics.
Brent crude futures, the global benchmark for oil, eased by 1.0% in early trade but stayed well above levels seen before the outbreak of hostilities. At the same time, yields on government bonds across the eurozone declined, reflecting shifting investor demand for fixed-income assets.
Market participants continue to worry that a jump in energy prices could stoke higher inflation, a dynamic likely to pressure central banks to tighten policy. The European Central Bank is widely expected to implement a rate increase on Thursday, according to market expectations, with policymakers prioritizing the rein in of price pressures even as growth in the 21-member eurozone shows signs of weakening.
Across the Atlantic, investors also anticipate a Federal Reserve rate increase before year-end, a view that has been reinforced by a robust May employment report released last week.
Away from geopolitical and macroeconomic developments, corporate news weighed on individual stocks. Shares of GlaxoSmithKline fell about 2.1% after the drugmaker said it had agreed to acquire cancer therapy group Nuvalent for $10.6 billion. The deal is set to provide GSK with access to three lung cancer drug candidates.
Market context and implications
The mixed performance among European indices reflects a balance between reduced threat perceptions from the Middle East and persistent concerns over energy-related inflation and central bank responses. Bond yields falling in the eurozone and a modest retreat in crude oil prices signal a complex backdrop in which monetary policy moves will be closely watched by investors.